Gene_Locus Report

Biblio print

Add to basket

Go to basket

Tree Display

AceDB Schema

XML Display

Feedback

Gene_locus Report for: human-RBBP9

Name Class
human-RBBP9Name Homo sapiens (Human) Retinoblastoma-binding protein 9 and 10 (rbbp-10) (b5t overexpressed gene protein) (bog protein)
SpeciesHomo sapiens
Organismhuman
Gene_nameRbbp9
BOG
RBBP10
DKFZp667H1113
BlockX
FamilyHydrolase_RBBP9_YdeN
Database (12)
Paper (18)
CommentRetinoblastoma binding protein 9 is an aminopeptidase with a preference for removing aromatic amino acids in human cells (Tang et al.) (from OMIM) Woitach et al. (1998) described a new gene, designated BOG (B5T overexpressed gene now RBBP9), which was shown to be overexpressed in several transformed rat liver epithelial cell lines resistant to the growth-inhibitory effect of TGF-beta-1 (TGFB1; 190180), as well as in primary human liver tumors. The Bog protein was found to share homology with other retinoblastoma-binding proteins and contained the RB1-binding motif LXCXE. Woitach et al. (1998) demonstrated that Bog binds to the RB1 gene product. In vivo, Bog/Rb complexes do not contain E2F1, and Bog can displace E2F1 from E2F1/Rb complexes in vitro. Overexpression of Bog in normal RLE cells conferred resistance to the growth-inhibitory effect of TGF-beta-1. Furthermore, normal RLE cells were rapidly transformed when Bog was continuously overexpressed and formed hepatoblastoma-like tumors when transplanted into nude mice. Bog may be important in the transformation process, in part due to its capacity to transfer resistance to the growth-inhibitory effects of TGF-beta-1 through interaction with RB1 and the subsequent displacement of E2F1. Chen et al. (2002) cloned RBBP9, which they called RBBP10. Structure of RBBP9 was determined by Vorobiev et al. 2009. Using an activity-based proteomic approach to identify serine hydrolases in pancreatic cancers, Shields et al. (2010) identified RBBP9. RBBP9 activity, but not expression, was elevated in pancreatic cancers compared with normal tissue. Knockdown of RBBP9 in FG human pancreatic carcinoma cells reduced cell proliferation and altered cell morphology in culture, reduced colony formation in soft agar, and reduced tumor formation in nude mice. Expression of RBBP9 reversed the antiproliferative effect of TGF-beta (TGFB1; 190180) in FG human pancreatic carcinoma cells and inhibited TGF-beta-dependent SMAD2 (601366)/SMAD3 (603109) phosphorylation. Mutation of ser75 within a predicted serine hydrolase motif abrogated all RBBP9 activity and functioned as a dominant-negative mutation, permitting unexpectedly elevated TGF-beta activity and SMAD2/SMAD3 phosphorylation. By yeast 2-hybrid screening of a human fetal brain library using RBBP9 (602908) as bait, Chen et al. (2003) cloned YRDC. The deduced 279-amino acid protein contains a SUA5-YCIO-YRDC domain, a GTP-binding elongation factor signature, and a leucine zipper motif.
Proteinhuman-RBBP9
Peptidehuman-RBBP9
Structure7OEX
2QS9
InhibitorPhenylalanine
Emetine
ML114
Ala(1-naph)-Pro-CN
Tree_nodeHydrolase_RBBP9_YdeN243992
Structure299961

Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer